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1. Introduction 
Local anaesthetics are potent inhibitors of 
hormone-stimulated lipolysis in isolated fat cells [l] . 
This inhibition is reversible and does not concur with 
a reduction in intracellular 3’:5’-AMP, but rather an 
increase at higher concentrations of the drug [l] . 
Since local anaesthetics affect ion translocation [2] , 
especially that of Ca’+ [3] , their antilipolytic effect 
was interpreted as indirect evidence for a central role 
of Ca’+-ions in the control of lipolysis [l] . This 
mechanism was cited as an analogy to the mechanism 
of action of insulin [4] , where a causal connection 
between 3’:5’-AMP and lipolysis in the fat cell has 
been questioned [5,6] , and where Ca*+ was implied 
as a possible messenger [4] . In view of the preliminary 
observation of an inhibition of catecholamine- 
stimulated adenylate cyclase in rat heart by lignocaine 
[7], it was of interest to extend this finding to the 
fat cell system. Because of its potent effect on lipo- 
lysis [l] tetracaine was used in most ofthe experiments. 
2. Experimental procedure 
Tetracaine hydrochloride (pantocain) was purchased 
from Hoechst, Frankfurt, norepinephrine bitartrate 
from Serva, Heidelberg, and isoproterenol from ICI- 
Pharma, Plankstadt. Human albumin was obtained 
from the Swiss Red Cross, Berne. Collagenase (lot 
CLSN 47B 177P) was from Worthington, creatine 
phosphokinase, ATP (disodium salt), cyclic 3’:5’- 
adenylic acid and all other biochemicals were from 
Boehringer Mannheim, 3’:5’-[ 3H]AMP from the 
Elsevier/North-Holkmd Biomedical Press 
New England Nuclear Corp.; [cx-~*P]ATP from the 
Radiochemical Centre, Amersham. A1203 (W 200, 
neutral) was from Woelm, Eschwege. All other 
chemicals were reagent grade from E. Merck, Darmstadt. 
2.1. Preparation of fat cells, fat-cell ghosts and fht-cell 
membranes 
Male Wistar rats of 120-l 50 g were used through- 
out. They had free access to normal laboratory chow 
and tap water. Preparation of lipocytes followed 
essentially the original method [8] , but with a modi- 
fied buffer system [9] . Incubation and determina- 
tion of 3’:5’-AMP has been described [lo] . Ghosts 
from fat cells were prepared according to [ 1 l] 
Plasma membranes were partially purified from 
isolated fat cells on a linear sucrose gradient accord- 
ing to [ 121. Both bands at p4”C of 1.180 and 1.185 
were pooled and used fresh for the adenylate cyclase 
assay. 
2.2. Adenylate cyclase assay 
Membrane preparations (50-100 pg protein) were 
incubated for 10 min at 37°C with the following 
additions: 20 mM Tris-HCl, pH 7.4,4.5 mM MgCl2, 
1 mM 3’:5’-AMP, 10 mM creatine phosphate, 300 
pg/ml creatine phosphokinase, 0.45 mM [(u-32P]ATP, 
albumin 176, and norepinephrine-HCl and tetracaine- 
HCl as indicated. Termination of the reaction and 
separation of 3’:5’-AMP was as in [ 131 . Protein was 
determined according to [ 141. 
3. Results 
At 1 mM, tetracaine was found to inhibit the effect 
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Table 1 
Inhibition of norepinephrine-stimulated adenylate cyclase 
activity in fat cell ghosts by tetracaine 
Additions Adenylate cyclase activiiy 
(nmol X g prot.-’ X min“) 
None 83* 7 
Norepinephrine, 0.1 mM 595 c 68 
Plus tetracaine, 1 mM 470 * 50a 
a p < 0.025, paired f-test 
Values indicate mean of 4 preparations * SEM 
of 0.1 mM norepinephrine upon adenylate cyclase 
activity in fat cell ghosts by about 21% (table 1). 
Lignocaine was much less potent with an inhibition 
of 18% at 6.4 mM under the same conditions. In a 
partially-purified plasma membrane preparation a 
gradual inhibition of the norepinephrine-stimulated 
system was observed, beginning at IO-’ M with a 
Nepi 10” M 
P , 
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Fig.1. Inhibition of basal, norepinephrine-and NaFstimulated 
adenylate cyclase activity of fat cell membranes. The reaction 
was started with the addition of plasma membranes. 
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Fig.2. Dose-response curve of norepinephrine in the presence 
and absence of 1 mM tetracaine. Adenylate cyclase activity 
was measured in fat-cell ghosts. 
complete Inhibition at lo-’ M tetracaine (fig.1). In 
contrast, both the basal and the NaF-stimulated 
activity was inhibited above 5 mM. At 1 mM tetra- 
tine, a small stimulation was observed from l-l 0 mM 
NaF (data no shown). This suggests interference with 
the coupling mechanism at lower, and a more direct 
attack at the catalytic subunit at higher, concentra- 
tions of the drug. An inhibitory effect was found 
throughout the dose-response range of norepineph- 
rine (fig.2). If one compares the effect of tetracaine 
on lipolysis in intact cells and adenylate cyclase 
activity in membranes (lig.3), a considerable dis- 
crepancy is observed (app. Ki of lipolysis, 0.6 mM; 
app. Ki of cyclase, 2.3 mM). 
In contrast to the observed inhibition of lipolysis 
and adenylate cyclase, no congruent drop of the levels 
of 3’:5’-AMP in the presence of 1 mM isoproterenol 
was observed (fig.4). Incubation of isolated fat cells 
with various concentrations of tetracaine resulted in 
a biphasic response of the levels of 3’:5’-AMP at 
5 min. Above 0.1 mM, where inhibition of lipolysis 
and adenylate cyclase was found (fig.1) the cyclic 
nucleotide levels were above those seen with iso- 
proterenol alone. Both, inhibition of the effect of 
isoproterenol at 1 I.IM tetracaine, and stimulation at 
1 mM, were significant (fig.4). 
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Fig.3. Comparison of tetracaine effect on norepinephrine- 
stimulated lipolysis in intact cells and adenylate cyclase 
activity in fat-cell membranes. Norepinephrine concentra- 
tion in both systems: 0.1 mM; incubation time for intact 
cells 60 min, for cyclase assay 10 min. Maximal effect in 
absence of tetracaine was set at 100%. 
4. Discussion 
At 1 mM pantocaine, a significant inhibition of the 
norepinephrine-stimulated adenylate cyclase system is 
observed without any effect on the basal or fluoride- 
stimulated enzyme. This suggests an inhibition of 
signal transfer rather than a direct effect on the 
catalytic unit which may occur at higher concentra- 
tions (fig.1). In the light of current theories on the 
mechanism of action of local anaesthetics [2] the 
present data do not provide any clue as to the under- 
lying mechanism. It could be due to an effect on ion 
translocation [ 151, membrane surface charge [ 161 or 
an increase in fluidity of the lipid phase from a 
crystalline, gel state to a liquid-crystalline state [ 171 
with a consequent relaxation of imbedded enzyme 
systems. It is also known that anaesthetic amines 
lower the phase transition temperature of membrane 
phospholipids [ 171 which are known to play a role 
in transducing hormone-receptor interaction into 
adenylate cyclase activation [ 181 . 
It is possible that the inhibitory effect at the 
cyclase step is causally related to the antilipolytic 
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Fig.4. Effect of tetracaine on levels of 3’:5’-AMP in fat cells 
in the presence of 1 FM isoproterenol without (closed circles) 
and with (open circles) 2 mM methyl-isobutyl-xanthine. 
Mean of 4 experiments r SEM the levels with isoproterenol 
alone (= 100%) were 27.0 + 1.8 pmol/lO’ cells after 5 min 
incubation.(basal levels: 3.0 ? 0.4 pmol/lO’ cells). Stimula- 
tion at 1 mM pantocaine and inhibition at 1 /.IM was signifi- 
cant in the absence of methyl-isobutyl-xanthine @ < 0.005, 
paired comparison). 
action in the intact cell. The discrepancy in half- 
maximal concentrations does not rule out such a 
relationship, since broken cell preparations may 
exhibit lower hormone sensitivity than intact cells. 
In accord with a central role of 3’:5’-AMP in the 
control of lipolysis, one would expect a drop in this 
nucleotide over approximately the same concentration 
range of pantocaine. However, the apparent incon- 
sistency between metabolic effects and intracellular 
levels of 3’:5’-AMP has already been pointed out [l] , 
and we find the highest levels of 3’:5’-AMP (143%) 
at concentrations where lipolysis is strongly inhibited. 
Yet a lack of correlation between levels of 3’:5’-AMP 
and metabolic response has been observed in other 
situations, and compartmentation of the cyclic 
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nucleotide has been suggested as a possible explana- 
tion [ 19,20]. Thus only a small fraction of the cyclic 
nucleotide in the fat cett may in fact be metaboIically 
active and responsible for the state of activation of 
the enzyme cascade controlling the activity of the 
triacylglycerol lipase. 
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